Capricor board member Manzo resigns; appoints Paul Auwaerter, M.D. to board

CAPRICOR THERAPEUTICS, INC.

Louis Manzo resigned from board effective July 11, 2023, with no disagreement over operations.
Manzo entered a consulting agreement to perform investor relations services for Capricor.
Paul Auwaerter, M.D. appointed to board; receives initial option grant of 115,000 shares vesting over 3 years.
Auwaerter is Clinical Director at Johns Hopkins Division of Infectious Diseases with over 30 years experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Louis Manzo

member of the Board of Directors

CAPR · CAPRICOR THERAPEUTICS, INC.

Effective: 2023-07-11
Filed: July 13, 2023, 7:59 PM ET

On July 11, 2023, Mr. Louis Manzo, a member of the Board of Directors (the “Board”) of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), resigned from the Board effective immediately.

Appointed

Paul Auwaerter

member of the Board of Directors

CAPR · CAPRICOR THERAPEUTICS, INC.

Effective: 2023-07-11
Filed: July 13, 2023, 7:59 PM ET

On July 11, 2023, the Board elected Paul Auwaerter, M.D. as a member of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Louis Manzo resigned as member of the Board of Directors at CAPRICOR THERAPEUTICS, INC..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On July 11, 2023, Mr. Louis Manzo, a member of the Board of Directors (the “Board”) of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), resigned from the Board effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Auwaerter was elected as member of the Board of Directors at CAPRICOR THERAPEUTICS, INC..

Action: elected
Role: member of the Board of Directors

Exact text from the filing

On July 11, 2023, the Board elected Paul Auwaerter, M.D. as a member of the Board, effective immediately.

View on SEC.gov

CAPRICOR THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-011854

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.